CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
Chlorhexidine Gluconatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03331263
NCT03331263Phase 1Completed

Single Dose Pharmacokinetic Study to Assess the Systemic Exposure of Chlorhexidine From ReadyPrep® CHG (2% Chlorhexidine Gluconate Cloth)

Medline Industries·interventional·Posted Nov 6, 2017·Updated Dec 15, 2023

In Brief

A Phase 1 clinical trial evaluating Chlorhexidine Gluconate for Surgical Skin Preparation. Completed, enrolled 12 participants across 1 site.

Detailed Summary

A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The treatments were separated by a wash-out of 7 calendar days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
201820192020202120222023202420252026
First PostedNov 6, 2017
Enrollment StartJul 21, 2017
Primary CompletionAug 6, 2017
TodayJul 2, 2026
Enrollment to primary: 15 daysPosted 8.7 years ago

Interventions

Chlorhexidine Gluconatedrug

2% CHG